Reference：
1. Liao S.L. et al. 2019. Trajectory of vitamin D, micronutrient status and c hildhood growth in exclusively breastfed children. Scientific Reports 9; 9:19070
2. Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 2012; 60: 139-56.
3. 國民健康署 2019. 國民營養健康狀況變遷調查(102-105 年)
4. 食品藥物管理署 2019. 食品及相關產品標示
5. 財團法人癌症希望基金會. 2018. 維他命D真的能抗癌嗎？ 網址：www.ecancer.org.tw/DynamicContent.aspx?unit ID=10137&conten
tID=1293 上網日期: 2021/06/24
6. National Health Service (UK). 2020. Free vitamin D supplements for
ople at high risk from coronavirus (COVID-19). Available at:https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-high er-risk/free-vit amin-d-supplements-for-people-at-high-risk/ Accessed 24 Jun 2021.
7. Paula M. O'Shea et al. 2020. COVID-19: the older adult and the
ance of vitamin D sufficiency. Journal of Nutritional Science 2020;
:p1-5
8. Harvey W Kaufman et al. 2020. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLOS ONE 2020; 0239252
9. Aleksandar Radujkovic et al. 2020. Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020; 12(9):2757
10. Ashu Rastogi et al. 2020. Short term, high-dose vitamin D supplementa tion for COVID-19 disease: a randomised, placebo-controlled, study HADE study). British medical journal 2020; 0:1-4
11. Marta Entrenas Castillo et al. 2020. Effect of calcifediol treatment and est available therapy versus best available therapy on intensive care un it admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol. 05751
12. Xavier Nogues et al. 2021. Calcifediol treatment and COVID-19-related outcomes. J Clin Endocrinol Metab. 2021;dgab405
13. 國人膳食營養素參考攝取量 第八
